338 related articles for article (PubMed ID: 12799554)
21. Subcutaneous Adipocyte Adenosine Triphosphate Levels in HIV Infected Patients.
Gojanovich GS; Shikuma CM; Milne C; Libutti DE; Chow DC; Gerschenson M
AIDS Res Hum Retroviruses; 2020 Jan; 36(1):75-82. PubMed ID: 31407586
[TBL] [Abstract][Full Text] [Related]
22. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
Mallal SA; John M; Moore CB; James IR; McKinnon EJ
AIDS; 2000 Jul; 14(10):1309-16. PubMed ID: 10930144
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy.
McComsey G; Tan DJ; Lederman M; Wilson E; Wong LJ
AIDS; 2002 Mar; 16(4):513-8. PubMed ID: 11872993
[TBL] [Abstract][Full Text] [Related]
24. Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion.
McComsey G; Bai RK; Maa JF; Seekins D; Wong LJ
J Acquir Immune Defic Syndr; 2005 Jun; 39(2):181-8. PubMed ID: 15905734
[TBL] [Abstract][Full Text] [Related]
25. The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial.
Menezes CN; Duarte R; Dickens C; Dix-Peek T; Van Amsterdam D; John MA; Ive P; Maskew M; Macphail P; Fox MP; Raal F; Sanne I; Crowther NJ
HIV Med; 2013 Apr; 14(4):217-25. PubMed ID: 23036096
[TBL] [Abstract][Full Text] [Related]
26. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.
McComsey GA; Paulsen DM; Lonergan JT; Hessenthaler SM; Hoppel CL; Williams VC; Fisher RL; Cherry CL; White-Owen C; Thompson KA; Ross ST; Hernandez JE; Ross LL
AIDS; 2005 Jan; 19(1):15-23. PubMed ID: 15627029
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.
Hammond E; McKinnon E; Nolan D
Clin Infect Dis; 2010 Sep; 51(5):591-9. PubMed ID: 20645860
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
Rabing Christensen E; Stegger M; Jensen-Fangel S; Laursen AL; Ostergaard L
Clin Infect Dis; 2004 Nov; 39(9):1371-9. PubMed ID: 15494915
[TBL] [Abstract][Full Text] [Related]
29. European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.
Hulgan T; Haubrich R; Riddler SA; Tebas P; Ritchie MD; McComsey GA; Haas DW; Canter JA
AIDS; 2011 Jan; 25(1):37-47. PubMed ID: 20871389
[TBL] [Abstract][Full Text] [Related]
30. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
[TBL] [Abstract][Full Text] [Related]
31. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406
[TBL] [Abstract][Full Text] [Related]
32. Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy.
Mashiko T; Tsukada K; Takada H; Wu SH; Kanayama K; Asahi R; Mori M; Kurisaki A; Oka S; Yoshimura K
AIDS Res Ther; 2022 Mar; 19(1):14. PubMed ID: 35246167
[TBL] [Abstract][Full Text] [Related]
33. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM
HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163
[TBL] [Abstract][Full Text] [Related]
34. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
Saint-Marc T; Partisani M; Poizot-Martin I; Bruno F; Rouviere O; Lang JM; Gastaut JA; Touraine JL
AIDS; 1999 Sep; 13(13):1659-67. PubMed ID: 10509567
[TBL] [Abstract][Full Text] [Related]
35. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
[TBL] [Abstract][Full Text] [Related]
36. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.
Nolan D; Mallal S
J HIV Ther; 2004 May; 9(2):34-40. PubMed ID: 15238874
[TBL] [Abstract][Full Text] [Related]
37. Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers.
ter Hofstede HJ; Willems HL; Koopmans PP
J Clin Virol; 2004 Jan; 29(1):44-50. PubMed ID: 14675869
[TBL] [Abstract][Full Text] [Related]
38. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy.
Shiramizu B; Shikuma KM; Kamemoto L; Gerschenson M; Erdem G; Pinti M; Cossarizza A; Shikuma C
J Acquir Immune Defic Syndr; 2003 Apr; 32(4):370-4. PubMed ID: 12640193
[TBL] [Abstract][Full Text] [Related]
39. Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Feeney ER; van Vonderen MG; Wit F; Danner SA; van Agtmael MA; Villarroya F; Domingo P; Capeau J; Reiss P; Mallon PW;
AIDS; 2012 Nov; 26(17):2165-74. PubMed ID: 22874517
[TBL] [Abstract][Full Text] [Related]
40. Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
Duvivier C; Ghosn J; Assoumou L; Soulié C; Peytavin G; Calvez V; Génin MA; Molina JM; Bouchaud O; Katlama C; Costagliola D;
J Antimicrob Chemother; 2008 Oct; 62(4):797-808. PubMed ID: 18641035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
